Gynaecological Cancers (eBook, ePUB)

Biology and Therapeutics
Redaktion: Kehoe, Sean

• Format: ePub

Produktbeschreibung

Gynaecological cancers are categorised as 'rare' diseases, although collectively they affect over 16,000 women each year in the UK alone. There is a lack of real understanding of these conditions compared with other malignancies, possibly owing to their relative rarity when viewed as individual diseases. The 60th RCOG Study Group brought together a range of experts to examine as many biological aspects of gynaecological cancers as possible, including both surgical and non-surgical therapies. This book presents the findings of the Study Group, with contents including: * current understanding of the biology of gynaecological cancers * translation of biology to the clinic * state of the art in imaging and therapy * current clinical trials * advances in multimodal therapy * individualised treatment.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Royal College of Obstetricians and Gynaecologists (RCOG)
• Erscheinungstermin: 1. Juni 2011
• Englisch
• ISBN-13: 9781107779907
• Artikelnr.: 52967994

Inhaltsangabe

Part I. Biology of Gynaecological Cancers: Our Current Understanding: 1.
Morphological sub-types of ovarian carcinoma: new developments and
pathogenesis W. Glenn McCluggage; 2. Novel treatment strategies for
targeting genetic changes in endometrial cancer Susana Banerjee; 3.
Epigenetic biomarkers in ovarian cancer Robert Brown and Janet Graham; 4.
Predictive biology of ovarian cancer Christine A. Parkinson and James D.
Brenton; Part II. The Translation of Biology to the Clinic: 5. Biology of
BRCA1 and BRCA2 genes and implications for cancer management Timothy A.
Yap, Yvette Drew and Susan Shanley; 6. Implications of homologous
recombination defectiveness in ovarian cancer Richard J. Edmondson, Asima
Mukhopadhyay, Aiste Cerbinskaite and Nicola J. Curtin; 7. The future of
PARP inhibitors in the treatment of cancer Yvette Drew, Timothy A. Yap and
Stan B. Kaye; Part III. Imaging and Therapy: State of the Art: 8. The role
of robotics and the future Tim Mould; 9. 'Ultra-radical' surgery in
advanced ovarian cancer Oliver Zivanovic and Dennis S. Chi; 10.
Antivascular therapy in gynaecological cancers Leena Mukherjee and Gordon
Rustin; 11. Oncolytic viral gene therapy in ovarian cancer Iain A. McNeish;
12. Endometrial cancer: what have the clinical trials taught us? Andrew
Clamp; 13. Targeting therapies in cancer: opportunities in ovarian cancer
Ahmed Ashour Ahmed, Stefan Knapp, Anil K. Sood and Robert C. Bast Jr; 14.
Functional imaging: from tumour biology to the clinic Nandita M. deSouza,
Evis Sala, Stavroula Kyriazi and Andrea Rockall; Part IV. What Questions
Are Being Asked by Current Clinical Trials?: 15. Current clinical trials in
ovarian cancer Christina Fotopoulou, Angus McIndoe, Jalid Sehouli and Hani
Gabra; 16. Clinical trials in cervical cancer Karen Tipples and Melanie
Powell; 17. Clinical trials in vulval cancer Tito Lopes; Part V. Consensus
Views: 18. Consensus views arising from the 60th Study Group:
Gynaecological Cancers: Biology and Therapeutics; Index.